LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

pubmed, article, google, scholar, dabrafenib, cas, melanoma, braf, central, cancer, patients, trametinib, metastatic, clin, pharmacokinetics, phase, drug, oncol, inhibitor, clinical, cell, long, dose, trial, lancet, inhibitors, france, combination, audrey, raf, paris, benoit, blanchet, kinase, med, pharmacol, mek, access, therapy, treatment, accessed, multicentre, openlabel, flaherty, combined, ther, engl, brain, toulouse, privacy,

Topics {✒️}

eu/docs/en_gb/document_library/epar_-_product_information/human/002604/wc500149671 eu/docs/en_gb/document_library/epar_-_public_assessment_report/human/002604/wc500149673 threonine-protein kinase b-raf braf-mutated high-grade glioma month download article/chapter gov/downloads/drugs/guidances/ucm070246 b-raf-driven tumors braf mutation-positive tumors val600 braf-mutant melanoma braf v600-mutant tumours p450-mediated ddi risk small-cell lung cancer carbon-carbon bond cleavage gov/drugsatfda_docs/nda/2013/202806orig1s000clinpharmr mitogen-activated protein kinase gov/ct2/show/nct02873650 metastatic braf-mutated melanoma braf-mutated metastatic melanoma cyp3a4/2b6/2c inducer benoit blanchet declare braf v600e mutation gov/drugsatfda_docs/label/2018/202806s010lbl trametinib combination therapy marie-noëlle paludetto drug–drug interactions audrey thomas-schoemann wild-type braf mapk-activated protein kinases braf-mutant kinase article puszkiel davies ma etienne chatelut full article pdf combination therapy braf v600 mutations privacy choices/manage cookies drug metab dispos therapeutic drug monitoring drug monitoring unit benoit blanchet dabrafenib-treated melanoma patients health-related quality braf-mutated melanoma raf inhibitors activate falchook gs untreated brain metastases braf inhibitors equal drug interaction potential mol cancer ther pharmacokinetic profile

Questions {❓}

• Paradoxical oncogenesis: are all BRAF inhibitors equal?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib
         description:Dabrafenib is a potent and selective inhibitor of BRAF-mutant kinase that is approved, as monotherapy or in combination with trametinib (mitogen-activated protein kinase (MAPK) kinase (MEK) inhibitor), for unresectable or metastatic BRAF-mutated melanoma, advanced non-small cell lung cancer and anaplastic thyroid cancer harbouring the BRAFV600E mutation. The recommended dose of dabrafenib is 150 mg twice daily (bid) under fasted conditions. After single oral administration of the recommended dose, the absolute oral bioavailability (F) of dabrafenib is 95%. Dabrafenib shows a time-dependent increase in apparent clearance (CL/F) following multiple doses, which is likely due to induction of its own metabolism through cytochrome P450 (CYP) 3A4. Therefore, steady state is reached only after 14 days of daily dose administration. Moreover, the extent of this auto-induction process is dependent on the dose, which explains why dabrafenib systemic exposure at steady state increases less than dose proportionally over the dose range of 75–300 mg bid. The main elimination route of dabrafenib is the oxidative metabolism via CYP3A4/2C8 and biliary excretion. Among the three major metabolites identified, hydroxy-dabrafenib appears to contribute to the pharmacological activity. Age, sex and body weight did not have any clinically significant influence on plasma exposure to dabrafenib. No dose adjustment is needed for patients with mild renal or hepatic impairment, whereas the impacts of severe impairment on dabrafenib pharmacokinetics remain unknown. Considering that dabrafenib is a substrate of CYP3A4/2C8 and is a CYP3A4/2B6/2C inducer, drug–drug interactions are expected with dabrafenib. The relationship between clinical outcomes and plasma exposure to dabrafenib and hydroxy-dabrafenib should be investigated more deeply.
         datePublished:2018-08-09T00:00:00Z
         dateModified:2018-08-09T00:00:00Z
         pageStart:451
         pageEnd:467
         sameAs:https://doi.org/10.1007/s40262-018-0703-0
         keywords:
            Pharmacotherapy
            Pharmacology/Toxicology
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs40262-018-0703-0/MediaObjects/40262_2018_703_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs40262-018-0703-0/MediaObjects/40262_2018_703_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs40262-018-0703-0/MediaObjects/40262_2018_703_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs40262-018-0703-0/MediaObjects/40262_2018_703_Fig4_HTML.png
         isPartOf:
            name:Clinical Pharmacokinetics
            issn:
               1179-1926
               0312-5963
            volumeNumber:58
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Alicja Puszkiel
               affiliation:
                     name:Université Paul Sabatier
                     address:
                        name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gaëlle Noé
               affiliation:
                     name:Bicetre Hospital, AP-HP
                     address:
                        name:Department of Pharmacology and Toxicology, Bicetre Hospital, AP-HP, Kremlin Bicetre, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Audrey Bellesoeur
               affiliation:
                     name:CERIA, CARPEM, Cochin University Hospital, APHP
                     address:
                        name:Department of Medical Oncology, CERIA, CARPEM, Cochin University Hospital, APHP, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:CERIA, CARPEM, Cochin University Hospital, AP-HP
                     address:
                        name:Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nora Kramkimel
               affiliation:
                     name:Cochin University Hospital, AP-HP
                     address:
                        name:Department of Dermatology, Cochin University Hospital, AP-HP, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marie-Noëlle Paludetto
               affiliation:
                     name:Université Paul Sabatier
                     address:
                        name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
                        type:PostalAddress
                     type:Organization
                     name:Institut Universitaire du Cancer de Toulouse - Oncopole
                     address:
                        name:Department of Pharmacy, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Audrey Thomas-Schoemann
               affiliation:
                     name:CERIA, CARPEM, Cochin University Hospital, AP-HP
                     address:
                        name:Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:University Paris Descartes, PRES Sorbonne Paris Cité
                     address:
                        name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michel Vidal
               affiliation:
                     name:University Paris Descartes, PRES Sorbonne Paris Cité
                     address:
                        name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:CERIA, CARPEM, Cochin University Hospital, AP-HP
                     address:
                        name:Department of Pharmacokinetics and Pharmacochemistry, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:François Goldwasser
               affiliation:
                     name:CERIA, CARPEM, Cochin University Hospital, APHP
                     address:
                        name:Department of Medical Oncology, CERIA, CARPEM, Cochin University Hospital, APHP, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Etienne Chatelut
               affiliation:
                     name:Université Paul Sabatier
                     address:
                        name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
                        type:PostalAddress
                     type:Organization
                     name:Institut Universitaire du Cancer de Toulouse - Oncopole
                     address:
                        name:Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
                        type:PostalAddress
                     type:Organization
                     name:Groupe de Pharmacologie Clinique Oncologique (GPCO)
                     address:
                        name:Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Benoit Blanchet
               affiliation:
                     name:University Paris Descartes, PRES Sorbonne Paris Cité
                     address:
                        name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:CERIA, CARPEM, Cochin University Hospital, AP-HP
                     address:
                        name:Department of Pharmacokinetics and Pharmacochemistry, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:Groupe de Pharmacologie Clinique Oncologique (GPCO)
                     address:
                        name:Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib
      description:Dabrafenib is a potent and selective inhibitor of BRAF-mutant kinase that is approved, as monotherapy or in combination with trametinib (mitogen-activated protein kinase (MAPK) kinase (MEK) inhibitor), for unresectable or metastatic BRAF-mutated melanoma, advanced non-small cell lung cancer and anaplastic thyroid cancer harbouring the BRAFV600E mutation. The recommended dose of dabrafenib is 150 mg twice daily (bid) under fasted conditions. After single oral administration of the recommended dose, the absolute oral bioavailability (F) of dabrafenib is 95%. Dabrafenib shows a time-dependent increase in apparent clearance (CL/F) following multiple doses, which is likely due to induction of its own metabolism through cytochrome P450 (CYP) 3A4. Therefore, steady state is reached only after 14 days of daily dose administration. Moreover, the extent of this auto-induction process is dependent on the dose, which explains why dabrafenib systemic exposure at steady state increases less than dose proportionally over the dose range of 75–300 mg bid. The main elimination route of dabrafenib is the oxidative metabolism via CYP3A4/2C8 and biliary excretion. Among the three major metabolites identified, hydroxy-dabrafenib appears to contribute to the pharmacological activity. Age, sex and body weight did not have any clinically significant influence on plasma exposure to dabrafenib. No dose adjustment is needed for patients with mild renal or hepatic impairment, whereas the impacts of severe impairment on dabrafenib pharmacokinetics remain unknown. Considering that dabrafenib is a substrate of CYP3A4/2C8 and is a CYP3A4/2B6/2C inducer, drug–drug interactions are expected with dabrafenib. The relationship between clinical outcomes and plasma exposure to dabrafenib and hydroxy-dabrafenib should be investigated more deeply.
      datePublished:2018-08-09T00:00:00Z
      dateModified:2018-08-09T00:00:00Z
      pageStart:451
      pageEnd:467
      sameAs:https://doi.org/10.1007/s40262-018-0703-0
      keywords:
         Pharmacotherapy
         Pharmacology/Toxicology
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs40262-018-0703-0/MediaObjects/40262_2018_703_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs40262-018-0703-0/MediaObjects/40262_2018_703_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs40262-018-0703-0/MediaObjects/40262_2018_703_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs40262-018-0703-0/MediaObjects/40262_2018_703_Fig4_HTML.png
      isPartOf:
         name:Clinical Pharmacokinetics
         issn:
            1179-1926
            0312-5963
         volumeNumber:58
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Alicja Puszkiel
            affiliation:
                  name:Université Paul Sabatier
                  address:
                     name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gaëlle Noé
            affiliation:
                  name:Bicetre Hospital, AP-HP
                  address:
                     name:Department of Pharmacology and Toxicology, Bicetre Hospital, AP-HP, Kremlin Bicetre, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Audrey Bellesoeur
            affiliation:
                  name:CERIA, CARPEM, Cochin University Hospital, APHP
                  address:
                     name:Department of Medical Oncology, CERIA, CARPEM, Cochin University Hospital, APHP, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:CERIA, CARPEM, Cochin University Hospital, AP-HP
                  address:
                     name:Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nora Kramkimel
            affiliation:
                  name:Cochin University Hospital, AP-HP
                  address:
                     name:Department of Dermatology, Cochin University Hospital, AP-HP, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marie-Noëlle Paludetto
            affiliation:
                  name:Université Paul Sabatier
                  address:
                     name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
                     type:PostalAddress
                  type:Organization
                  name:Institut Universitaire du Cancer de Toulouse - Oncopole
                  address:
                     name:Department of Pharmacy, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Audrey Thomas-Schoemann
            affiliation:
                  name:CERIA, CARPEM, Cochin University Hospital, AP-HP
                  address:
                     name:Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:University Paris Descartes, PRES Sorbonne Paris Cité
                  address:
                     name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michel Vidal
            affiliation:
                  name:University Paris Descartes, PRES Sorbonne Paris Cité
                  address:
                     name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:CERIA, CARPEM, Cochin University Hospital, AP-HP
                  address:
                     name:Department of Pharmacokinetics and Pharmacochemistry, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:François Goldwasser
            affiliation:
                  name:CERIA, CARPEM, Cochin University Hospital, APHP
                  address:
                     name:Department of Medical Oncology, CERIA, CARPEM, Cochin University Hospital, APHP, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Etienne Chatelut
            affiliation:
                  name:Université Paul Sabatier
                  address:
                     name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
                     type:PostalAddress
                  type:Organization
                  name:Institut Universitaire du Cancer de Toulouse - Oncopole
                  address:
                     name:Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
                     type:PostalAddress
                  type:Organization
                  name:Groupe de Pharmacologie Clinique Oncologique (GPCO)
                  address:
                     name:Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Benoit Blanchet
            affiliation:
                  name:University Paris Descartes, PRES Sorbonne Paris Cité
                  address:
                     name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:CERIA, CARPEM, Cochin University Hospital, AP-HP
                  address:
                     name:Department of Pharmacokinetics and Pharmacochemistry, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:Groupe de Pharmacologie Clinique Oncologique (GPCO)
                  address:
                     name:Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical Pharmacokinetics
      issn:
         1179-1926
         0312-5963
      volumeNumber:58
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Université Paul Sabatier
      address:
         name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
         type:PostalAddress
      name:Bicetre Hospital, AP-HP
      address:
         name:Department of Pharmacology and Toxicology, Bicetre Hospital, AP-HP, Kremlin Bicetre, France
         type:PostalAddress
      name:CERIA, CARPEM, Cochin University Hospital, APHP
      address:
         name:Department of Medical Oncology, CERIA, CARPEM, Cochin University Hospital, APHP, Paris, France
         type:PostalAddress
      name:CERIA, CARPEM, Cochin University Hospital, AP-HP
      address:
         name:Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
         type:PostalAddress
      name:Cochin University Hospital, AP-HP
      address:
         name:Department of Dermatology, Cochin University Hospital, AP-HP, Paris, France
         type:PostalAddress
      name:Université Paul Sabatier
      address:
         name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
         type:PostalAddress
      name:Institut Universitaire du Cancer de Toulouse - Oncopole
      address:
         name:Department of Pharmacy, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
         type:PostalAddress
      name:CERIA, CARPEM, Cochin University Hospital, AP-HP
      address:
         name:Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
         type:PostalAddress
      name:University Paris Descartes, PRES Sorbonne Paris Cité
      address:
         name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
         type:PostalAddress
      name:University Paris Descartes, PRES Sorbonne Paris Cité
      address:
         name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
         type:PostalAddress
      name:CERIA, CARPEM, Cochin University Hospital, AP-HP
      address:
         name:Department of Pharmacokinetics and Pharmacochemistry, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
         type:PostalAddress
      name:CERIA, CARPEM, Cochin University Hospital, APHP
      address:
         name:Department of Medical Oncology, CERIA, CARPEM, Cochin University Hospital, APHP, Paris, France
         type:PostalAddress
      name:Université Paul Sabatier
      address:
         name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
         type:PostalAddress
      name:Institut Universitaire du Cancer de Toulouse - Oncopole
      address:
         name:Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
         type:PostalAddress
      name:Groupe de Pharmacologie Clinique Oncologique (GPCO)
      address:
         name:Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France
         type:PostalAddress
      name:University Paris Descartes, PRES Sorbonne Paris Cité
      address:
         name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
         type:PostalAddress
      name:CERIA, CARPEM, Cochin University Hospital, AP-HP
      address:
         name:Department of Pharmacokinetics and Pharmacochemistry, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
         type:PostalAddress
      name:Groupe de Pharmacologie Clinique Oncologique (GPCO)
      address:
         name:Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Alicja Puszkiel
      affiliation:
            name:Université Paul Sabatier
            address:
               name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
               type:PostalAddress
            type:Organization
      name:Gaëlle Noé
      affiliation:
            name:Bicetre Hospital, AP-HP
            address:
               name:Department of Pharmacology and Toxicology, Bicetre Hospital, AP-HP, Kremlin Bicetre, France
               type:PostalAddress
            type:Organization
      name:Audrey Bellesoeur
      affiliation:
            name:CERIA, CARPEM, Cochin University Hospital, APHP
            address:
               name:Department of Medical Oncology, CERIA, CARPEM, Cochin University Hospital, APHP, Paris, France
               type:PostalAddress
            type:Organization
            name:CERIA, CARPEM, Cochin University Hospital, AP-HP
            address:
               name:Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
               type:PostalAddress
            type:Organization
      name:Nora Kramkimel
      affiliation:
            name:Cochin University Hospital, AP-HP
            address:
               name:Department of Dermatology, Cochin University Hospital, AP-HP, Paris, France
               type:PostalAddress
            type:Organization
      name:Marie-Noëlle Paludetto
      affiliation:
            name:Université Paul Sabatier
            address:
               name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
               type:PostalAddress
            type:Organization
            name:Institut Universitaire du Cancer de Toulouse - Oncopole
            address:
               name:Department of Pharmacy, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
               type:PostalAddress
            type:Organization
      name:Audrey Thomas-Schoemann
      affiliation:
            name:CERIA, CARPEM, Cochin University Hospital, AP-HP
            address:
               name:Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
               type:PostalAddress
            type:Organization
            name:University Paris Descartes, PRES Sorbonne Paris Cité
            address:
               name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
               type:PostalAddress
            type:Organization
      name:Michel Vidal
      affiliation:
            name:University Paris Descartes, PRES Sorbonne Paris Cité
            address:
               name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
               type:PostalAddress
            type:Organization
            name:CERIA, CARPEM, Cochin University Hospital, AP-HP
            address:
               name:Department of Pharmacokinetics and Pharmacochemistry, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
               type:PostalAddress
            type:Organization
      name:François Goldwasser
      affiliation:
            name:CERIA, CARPEM, Cochin University Hospital, APHP
            address:
               name:Department of Medical Oncology, CERIA, CARPEM, Cochin University Hospital, APHP, Paris, France
               type:PostalAddress
            type:Organization
      name:Etienne Chatelut
      affiliation:
            name:Université Paul Sabatier
            address:
               name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
               type:PostalAddress
            type:Organization
            name:Institut Universitaire du Cancer de Toulouse - Oncopole
            address:
               name:Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
               type:PostalAddress
            type:Organization
            name:Groupe de Pharmacologie Clinique Oncologique (GPCO)
            address:
               name:Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France
               type:PostalAddress
            type:Organization
      name:Benoit Blanchet
      affiliation:
            name:University Paris Descartes, PRES Sorbonne Paris Cité
            address:
               name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
               type:PostalAddress
            type:Organization
            name:CERIA, CARPEM, Cochin University Hospital, AP-HP
            address:
               name:Department of Pharmacokinetics and Pharmacochemistry, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
               type:PostalAddress
            type:Organization
            name:Groupe de Pharmacologie Clinique Oncologique (GPCO)
            address:
               name:Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
      name:Department of Pharmacology and Toxicology, Bicetre Hospital, AP-HP, Kremlin Bicetre, France
      name:Department of Medical Oncology, CERIA, CARPEM, Cochin University Hospital, APHP, Paris, France
      name:Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
      name:Department of Dermatology, Cochin University Hospital, AP-HP, Paris, France
      name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
      name:Department of Pharmacy, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
      name:Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
      name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
      name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
      name:Department of Pharmacokinetics and Pharmacochemistry, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
      name:Department of Medical Oncology, CERIA, CARPEM, Cochin University Hospital, APHP, Paris, France
      name:Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France
      name:Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
      name:Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France
      name:UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
      name:Department of Pharmacokinetics and Pharmacochemistry, CERIA, CARPEM, Cochin University Hospital, AP-HP, Paris, France
      name:Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(242)

• Learn how profitable https://www.springernature.com/gp/authors is on a monthly basis
• What are the earnings of https://link.springernature.com/home/?
• Find out how much https://order.springer.com/public/cart earns monthly
• How much does https://www.editorialmanager.com/cpka/ earn?
• Explore the financials of https://www.springernature.com/gp/librarians/licensing/agc/journals
• https://doi.org/10.1128%2FMMBR.00031-10's total income per month
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21372320?
• Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063353
• What's the income of http://scholar.google.com/scholar_lookup?&title=Activation%20and%20function%20of%20the%20MAPKs%20and%20their%20substrates%2C%20the%20MAPK-activated%20protein%20kinases&journal=Microbiol%20Mol%20Biol%20Rev&doi=10.1128%2FMMBR.00031-10&volume=75&pages=50-83&publication_year=2011&author=Cargnello%2CM&author=Roux%2CPP?
• Discover the revenue of https://doi.org/10.1038%2Fnature00766
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12068308 generate monthly?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Mutations%20of%20the%20BRAF%20gene%20in%20human%20cancer&journal=Nature&doi=10.1038%2Fnature00766&volume=417&pages=949-954&publication_year=2002&author=Davies%2CH&author=Bignell%2CGR&author=Cox%2CC&author=Stephens%2CP&author=Edkins%2CS&author=Clegg%2CS earns monthly
• How much does https://doi.org/10.1200%2FJCO.2010.32.4327 pull in?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21343559's gross income?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Prognostic%20and%20clinicopathologic%20associations%20of%20oncogenic%20BRAF%20in%20metastatic%20melanoma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2010.32.4327&volume=29&pages=1239-1246&publication_year=2011&author=Long%2CGV&author=Menzies%2CAM&author=Nagrial%2CAM&author=Haydu%2CLE&author=Hamilton%2CAL&author=Mann%2CGJ
• How much income does http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002604/WC500149671.pdf have?
• What's the revenue for https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202806s010lbl.pdf?
• How much profit does https://doi.org/10.1016%2FS0140-6736%2812%2960868-X generate?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22735384's financial summary
• What's the income of http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20in%20BRAF-mutated%20metastatic%20melanoma%3A%20a%20multicentre%2C%20open-label%2C%20phase%203%20randomised%20controlled%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2812%2960868-X&volume=380&pages=358-365&publication_year=2012&author=Hauschild%2CA&author=Grob%2CJ-J&author=Demidov%2CLV&author=Jouary%2CT&author=Gutzmer%2CR&author=Millward%2CM?
• Income figures for https://doi.org/10.1093%2Fannonc%2Fmdx176
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28475671 earn?
• What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834102?
• http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20plus%20trametinib%20versus%20dabrafenib%20monotherapy%20in%20patients%20with%20metastatic%20BRAF%20V600E%2FK-mutant%20melanoma%3A%20long-term%20survival%20and%20safety%20analysis%20of%20a%20phase%203%20study&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdx176&volume=28&pages=1631-1639&publication_year=2017&author=Long%2CGV&author=Flaherty%2CKT&author=Stroyakovskiy%2CD&author=Gogas%2CH&author=Levchenko%2CE&author=Braud%2CF's total income per month
• How much money does https://doi.org/10.1200%2FJCO.2015.63.2471 generate?
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26392102
• What are the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669588?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Combined%20BRAF%20and%20MEK%20inhibition%20with%20dabrafenib%20and%20trametinib%20in%20BRAF%20V600-mutant%20colorectal%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2015.63.2471&volume=33&pages=4023-4031&publication_year=2015&author=Corcoran%2CRB&author=Atreya%2CCE&author=Falchook%2CGS&author=Kwak%2CEL&author=Ryan%2CDP&author=Bendell%2CJC earns monthly
• How much does https://doi.org/10.6004%2Fjnccn.2017.7032 gross monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Rapid%20clinical%20and%20radiographic%20response%20with%20combined%20dabrafenib%20and%20trametinib%20in%20adults%20with%20BRAF-mutated%20high-grade%20glioma&journal=J%20Natl%20Compr%20Cancer%20Netw&doi=10.6004%2Fjnccn.2017.7032&volume=16&pages=4-10&publication_year=2018&author=Johanns%2CTM&author=Ferguson%2CCJ&author=Grierson%2CPM&author=Dahiya%2CS&author=Ansstas%2CG make?
• How much does https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/202806Orig1s000ClinPharmR.pdf bring in each month?
• http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002604/WC500149673.pdf income
• How much money does https://www.fda.gov/downloads/Drugs/Guidances/ucm070246.pdf generate?
• Learn how profitable https://doi.org/10.1002%2Fjps.23519 is on a monthly basis
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23608920?
• Profit of http://scholar.google.com/scholar_lookup?&title=Effects%20of%20particle%20size%2C%20food%2C%20and%20capsule%20shell%20composition%20on%20the%20oral%20bioavailability%20of%20dabrafenib%2C%20a%20BRAF%20inhibitor%2C%20in%20patients%20with%20BRAF%20mutation-positive%20tumors&journal=J%20Pharm%20Sci&doi=10.1002%2Fjps.23519&volume=102&pages=3100-3109&publication_year=2013&author=Ouellet%2CD&author=Grossmann%2CKF&author=Limentani%2CG&author=Nebot%2CN&author=Lan%2CK&author=Knowles%2CL
• Profit of https://doi.org/10.1021%2Fml4000063
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24900673 gross monthly?
• What is the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027516?
• How much money does http://scholar.google.com/scholar_lookup?&title=Discovery%20of%20dabrafenib%3A%20a%20selective%20inhibitor%20of%20Raf%20kinases%20with%20antitumor%20activity%20against%20B-Raf-driven%20tumors&journal=ACS%20Med%20Chem%20Lett&doi=10.1021%2Fml4000063&volume=4&pages=358-362&publication_year=2013&author=Rheault%2CTR&author=Stellwagen%2CJC&author=Adjabeng%2CGM&author=Hornberger%2CKR&author=Petrov%2CKG&author=Waterson%2CAG make?
• What's the revenue for https://doi.org/10.1371%2Fjournal.pone.0067583?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23844038 generate monthly?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701070?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Dabrafenib%3B%20preclinical%20characterization%2C%20increased%20efficacy%20when%20combined%20with%20trametinib%2C%20while%20BRAF%2FMEK%20tool%20combination%20reduced%20skin%20lesions&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0067583&volume=8&publication_year=2013&author=King%2CAJ&author=Arnone%2CMR&author=Bleam%2CMR&author=Moss%2CKG&author=Yang%2CJ&author=Fedorowicz%2CKE
• How much income does https://doi.org/10.1158%2F1535-7163.TARG-09-B88 have?
• How much does http://scholar.google.com/scholar_lookup?&title=A%20selective%20Raf%20kinase%20inhibitor%20induces%20cell%20death%20and%20tumor%20regression%20of%20human%20cancer%20cell%20lines%20encoding%20B-RafV600E%20mutation%20%5Babstract%20no.%20B88%5D&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.TARG-09-B88&volume=8&issue=12%20Suppl&publication_year=2009&author=Laquerre%2CS&author=Arnone%2CM&author=Moss%2CK&author=Yang%2CJ&author=Fisher%2CK&author=Kane-Carson%2CLS gross monthly?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23317446?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586362 gross monthly?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Effect%20of%20dabrafenib%20on%20melanoma%20cell%20lines%20harbouring%20the%20BRAF%28V600D%2FR%29%20mutations&journal=BMC%20Cancer&doi=10.1186%2F1471-2407-13-17&volume=13&publication_year=2013&author=Gentilcore%2CG&author=Madonna%2CG&author=Mozzillo%2CN&author=Ribas%2CA&author=Cossu%2CA&author=Palmieri%2CG bring in?
• What's the income generated by https://doi.org/10.1158%2F1535-7163.MCT-10-0181 each month?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20663930 make?
• How much income does http://scholar.google.com/scholar_lookup?&title=Selective%20and%20potent%20Raf%20inhibitors%20paradoxically%20stimulate%20normal%20cell%20proliferation%20and%20tumor%20growth&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-10-0181&volume=9&pages=2399-2410&publication_year=2010&author=Carnahan%2CJ&author=Beltran%2CPJ&author=Babij%2CC&author=Le%2CQ&author=Rose%2CMJ&author=Vonderfecht%2CS have?
• How much does https://doi.org/10.1038%2Fnature08833 bring in each month?
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20130576?
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=RAF%20inhibitors%20prime%20wild-type%20RAF%20to%20activate%20the%20MAPK%20pathway%20and%20enhance%20growth&journal=Nature&doi=10.1038%2Fnature08833&volume=464&pages=431-435&publication_year=2010&author=Hatzivassiliou%2CG&author=Song%2CK&author=Yen%2CI&author=Brandhuber%2CBJ&author=Anderson%2CDJ&author=Alvarado%2CR?
• What are the earnings of https://doi.org/10.1016%2Fj.cell.2009.12.040?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20141835?
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872605 income
• How much does http://scholar.google.com/scholar_lookup?&title=Kinase-dead%20BRAF%20and%20oncogenic%20RAS%20cooperate%20to%20drive%20tumor%20progression%20through%20CRAF&journal=Cell&doi=10.1016%2Fj.cell.2009.12.040&volume=140&pages=209-221&publication_year=2010&author=Heidorn%2CSJ&author=Milagre%2CC&author=Whittaker%2CS&author=Nourry%2CA&author=Niculescu-Duvas%2CI&author=Dhomen%2CN make?
• How much money does https://doi.org/10.1038%2Fnature08902 generate?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20179705's gross income?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178447?
• How much does http://scholar.google.com/scholar_lookup?&title=RAF%20inhibitors%20transactivate%20RAF%20dimers%20and%20ERK%20signalling%20in%20cells%20with%20wild-type%20BRAF&journal=Nature&doi=10.1038%2Fnature08902&volume=464&pages=427-430&publication_year=2010&author=Poulikakos%2CPI&author=Zhang%2CC&author=Bollag%2CG&author=Shokat%2CKM&author=Rosen%2CN rake in every month?
• Revenue of https://doi.org/10.1016%2Fj.ccr.2013.03.033
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23680146 is on a monthly basis
• How much does http://scholar.google.com/scholar_lookup?&title=RAF%20inhibitors%20activate%20the%20MAPK%20pathway%20by%20relieving%20inhibitory%20autophosphorylation&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2013.03.033&volume=23&pages=594-602&publication_year=2013&author=Holderfield%2CM&author=Merritt%2CH&author=Chan%2CJ&author=Wallroth%2CM&author=Tandeske%2CL&author=Zhai%2CH rake in every month?
• Income figures for https://doi.org/10.1056%2FNEJMoa1103782
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21639808?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549296?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Improved%20survival%20with%20vemurafenib%20in%20melanoma%20with%20BRAF%20V600E%20mutation&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1103782&volume=364&pages=2507-2516&publication_year=2011&author=Chapman%2CPB&author=Hauschild%2CA&author=Robert%2CC&author=Haanen%2CJB&author=Ascierto%2CP&author=Larkin%2CJ
• What is the earnings of https://doi.org/10.1056%2FNEJMoa1002011?
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20818844
• Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724529
• How much does http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20mutated%2C%20activated%20BRAF%20in%20metastatic%20melanoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1002011&volume=363&pages=809-819&publication_year=2010&author=Flaherty%2CKT&author=Puzanov%2CI&author=Kim%2CKB&author=Ribas%2CA&author=McArthur%2CGA&author=Sosman%2CJA earn?
• How much income does https://doi.org/10.3816%2FCGC.2009.n.003 have?
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19213663
• Discover the revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825856
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Cutaneous%20squamous%20cell%20carcinoma%20and%20inflammation%20of%20actinic%20keratoses%20associated%20with%20sorafenib&journal=Clin%20Genitourin%20Cancer&doi=10.3816%2FCGC.2009.n.003&volume=7&pages=20-23&publication_year=2009&author=Dubauskas%2CZ&author=Kunishige%2CJ&author=Prieto%2CVG&author=Jonasch%2CE&author=Hwu%2CP&author=Tannir%2CNM produce monthly?
• What's the financial intake of https://doi.org/10.1124%2Fdmd.113.053785?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24097902?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Metabolism%20and%20disposition%20of%20oral%20dabrafenib%20in%20cancer%20patients%3A%20proposed%20participation%20of%20aryl%20nitrogen%20in%20carbon-carbon%20bond%20cleavage%20via%20decarboxylation%20following%20enzymatic%20oxidation&journal=Drug%20Metab%20Dispos&doi=10.1124%2Fdmd.113.053785&volume=41&pages=2215-2224&publication_year=2013&author=Bershas%2CDA&author=Ouellet%2CD&author=Mamaril-Fishman%2CDB&author=Nebot%2CN&author=Carson%2CSW&author=Blackman%2CSC
• How much does http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20and%20its%20potential%20for%20the%20treatment%20of%20metastatic%20melanoma&journal=Drug%20Des%20Dev%20Ther&volume=6&pages=391-405&publication_year=2012&author=Menzies%2CA&author=Long%2CG&author=Murali%2CR pull in monthly?
• Earnings of https://doi.org/10.1111%2Fpcmr.12132
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23795808 make?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Paradoxical%20oncogenesis%3A%20are%20all%20BRAF%20inhibitors%20equal%3F&journal=Pigment%20Cell%20Melanoma%20Res&doi=10.1111%2Fpcmr.12132&volume=26&pages=611-615&publication_year=2013&author=Menzies%2CAM&author=Kefford%2CRF&author=Long%2CGV have monthly?
• How much does https://doi.org/10.1056%2FNEJMoa1210093 net monthly?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23020132?
• How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549295 generate?
• How much does http://scholar.google.com/scholar_lookup?&title=Combined%20BRAF%20and%20MEK%20inhibition%20in%20melanoma%20with%20BRAF%20V600%20mutations&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1210093&volume=367&pages=1694-1703&publication_year=2012&author=Flaherty%2CKT&author=Infante%2CJR&author=Daud%2CA&author=Gonzalez%2CR&author=Kefford%2CRF&author=Sosman%2CJ net monthly?
• Financial intake of https://doi.org/10.1016%2FS0140-6736%2815%2960898-4
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26037941
• How much does http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20and%20trametinib%20versus%20dabrafenib%20and%20placebo%20for%20Val600%20BRAF-mutant%20melanoma%3A%20a%20multicentre%2C%20double-blind%2C%20phase%203%20randomised%20controlled%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2815%2960898-4&volume=386&pages=444-451&publication_year=2015&author=Long%2CGV&author=Stroyakovskiy%2CD&author=Gogas%2CH&author=Levchenko%2CE&author=Braud%2CF&author=Larkin%2CJ pull in monthly?
• Income figures for https://doi.org/10.1016%2FS1470-2045%2815%2900087-X
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26433819
• Profit of http://scholar.google.com/scholar_lookup?&title=Comparison%20of%20dabrafenib%20and%20trametinib%20combination%20therapy%20with%20vemurafenib%20monotherapy%20on%20health-related%20quality%20of%20life%20in%20patients%20with%20unresectable%20or%20metastatic%20cutaneous%20BRAF%20Val600-mutation-positive%20melanoma%20%28COMBI-v%29%3A%20results%20of%20a%20phase%203%2C%20open-l&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2815%2900087-X&volume=16&pages=1389-1398&publication_year=2015&author=Grob%2CJJ&author=Amonkar%2CMM&author=Karaszewska%2CB&author=Schachter%2CJ&author=Dummer%2CR&author=Mackiewicz%2CA
• Income figures for https://doi.org/10.1056%2FNEJMoa1708539
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28891408 pull in monthly?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Adjuvant%20dabrafenib%20plus%20trametinib%20in%20stage%20III%20BRAF-mutated%20melanoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1708539&volume=377&pages=1813-1823&publication_year=2017&author=Long%2CGV&author=Hauschild%2CA&author=Santinami%2CM&author=Atkinson%2CV&author=Mandal%C3%A0%2CM&author=Chiarion-Sileni%2CV
• Financial intake of https://doi.org/10.1016%2FS1470-2045%2816%2900077-2
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27080216?
• What's http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006181's gross income?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20in%20patients%20with%20BRAFV600E-positive%20advanced%20non-small-cell%20lung%20cancer%3A%20a%20single-arm%2C%20multicentre%2C%20open-label%2C%20phase%202%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2816%2900077-2&volume=17&pages=642-650&publication_year=2016&author=Planchard%2CD&author=Kim%2CTM&author=Mazieres%2CJ&author=Quoix%2CE&author=Riely%2CG&author=Barlesi%2CF
• How much revenue does https://doi.org/10.1016%2FS1470-2045%2816%2930146-2 produce monthly?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27283860
• Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993103
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20plus%20trametinib%20in%20patients%20with%20previously%20treated%20BRAF%20V600E%20-mutant%20metastatic%20non-small%20cell%20lung%20cancer%3A%20an%20open-label%2C%20multicentre%20phase%202%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2816%2930146-2&volume=17&pages=984-993&publication_year=2016&author=Planchard%2CD&author=Besse%2CB&author=Groen%2CHJM&author=Souquet%2CP-J&author=Quoix%2CE&author=Baik%2CCS generate?
• How much does https://doi.org/10.1016%2FS1470-2045%2817%2930679-4 gross monthly?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28919011?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20plus%20trametinib%20in%20patients%20with%20previously%20untreated%20BRAF%20V600E%20-mutant%20metastatic%20non-small-cell%20lung%20cancer%3A%20an%20open-label%2C%20phase%202%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2817%2930679-4&volume=18&pages=1307-1316&publication_year=2017&author=Planchard%2CD&author=Smit%2CEF&author=Groen%2CHJM&author=Mazieres%2CJ&author=Besse%2CB&author=Helland%2C%C3%85 is on a monthly basis
• How much revenue does https://doi.org/10.1200%2FJCO.2017.73.6785 generate?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29072975?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20and%20trametinib%20treatment%20in%20patients%20with%20locally%20advanced%20or%20metastatic%20BRAF%20V600-mutant%20anaplastic%20thyroid%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2017.73.6785&volume=36&pages=7-13&publication_year=2018&author=Subbiah%2CV&author=Kreitman%2CRJ&author=Wainberg%2CZA&author=Cho%2CJY&author=Schellens%2CJHM&author=Soria%2CJC?
• See how much https://doi.org/10.1016%2FS1470-2045%2812%2970431-X makes per month
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23051966?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20in%20patients%20with%20Val600Glu%20or%20Val600Lys%20BRAF-mutant%20melanoma%20metastatic%20to%20the%20brain%20%28BREAK-MB%29%3A%20a%20multicentre%2C%20open-label%2C%20phase%202%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2812%2970431-X&volume=13&pages=1087-1095&publication_year=2012&author=Long%2CGV&author=Trefzer%2CU&author=Davies%2CMA&author=Kefford%2CRF&author=Ascierto%2CPA&author=Chapman%2CPB earns monthly
• How much revenue does https://doi.org/10.1016%2FS0140-6736%2812%2960398-5 generate?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22608338
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109288
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20in%20patients%20with%20melanoma%2C%20untreated%20brain%20metastases%2C%20and%20other%20solid%20tumours%3A%20a%20phase%201%20dose-escalation%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2812%2960398-5&volume=379&pages=1893-1901&publication_year=2012&author=Falchook%2CGS&author=Long%2CGV&author=Kurzrock%2CR&author=Kim%2CKB&author=Arkenau%2CTH&author=Brown%2CMP
• How profitable is https://doi.org/10.1016%2FS1470-2045%2817%2930429-1?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28592387
• Profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991615
• How much does http://scholar.google.com/scholar_lookup?&title=Dabrafenib%20plus%20trametinib%20in%20patients%20with%20BRAFV600-mutant%20melanoma%20brain%20metastases%20%28COMBI-MB%29%3A%20a%20multicentre%2C%20multicohort%2C%20open-label%2C%20phase%202%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2817%2930429-1&volume=18&pages=863-873&publication_year=2017&author=Davies%2CMA&author=Saiag%2CP&author=Robert%2CC&author=Grob%2CJ-J&author=Flaherty%2CKT&author=Arance%2CA bring in each month?
• How much profit does https://doi.org/10.1001%2Fjamadermatol.2015.1745 make?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26200476?
• How much does http://scholar.google.com/scholar_lookup?&title=Cutaneous%20toxic%20effects%20of%20BRAF%20inhibitors%20alone%20and%20in%20combination%20with%20MEK%20inhibitors%20for%20metastatic%20melanoma&journal=JAMA%20Dermatol&doi=10.1001%2Fjamadermatol.2015.1745&volume=151&pages=1103-1109&publication_year=2015&author=Carlos%2CG&author=Anforth%2CR&author=Clements%2CA&author=Menzies%2CAM&author=Carlino%2CMS&author=Chou%2CS gross monthly?
• How much does https://doi.org/10.1056%2FNEJMoa1203421 net monthly?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22663011 bring in?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Improved%20survival%20with%20MEK%20inhibition%20in%20BRAF-mutated%20melanoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1203421&volume=367&pages=107-114&publication_year=2012&author=Flaherty%2CKT&author=Robert%2CC&author=Hersey%2CP&author=Nathan%2CP&author=Garbe%2CC&author=Milhem%2CM have monthly?
• Revenue of https://doi.org/10.1158%2F1078-0432.CCR-14-0887
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24958809 generate monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Dose%20selection%2C%20pharmacokinetics%2C%20and%20pharmacodynamics%20of%20BRAF%20inhibitor%20dabrafenib%20%28GSK2118436%29&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-14-0887&volume=20&pages=4449-4458&publication_year=2014&author=Falchook%2CGS&author=Long%2CGV&author=Kurzrock%2CR&author=Kim%2CKB&author=Arkenau%2CH-T&author=Brown%2CMP bring in each month?
• Monthly income for https://doi.org/10.1002%2Fjcph.127
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23846776?
• How much income is http://scholar.google.com/scholar_lookup?&title=Concomitant%20oral%20and%20intravenous%20pharmacokinetics%20of%20dabrafenib%2C%20a%20BRAF%20inhibitor%2C%20in%20patients%20with%20BRAF%20V600%20mutation-positive%20solid%20tumors&journal=J%20Clin%20Pharmacol&doi=10.1002%2Fjcph.127&volume=53&pages=955-961&publication_year=2013&author=Denton%2CCL&author=Minthorn%2CE&author=Carson%2CSW&author=Young%2CGC&author=Richards-Peterson%2CLE&author=Botbyl%2CJ earning monthly?
• What is the monthly revenue of https://doi.org/10.1002%2Fjcph.437?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25449654 is on a monthly basis
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Assessment%20of%20the%20drug%20interaction%20potential%20and%20single-%20and%20repeat-dose%20pharmacokinetics%20of%20the%20BRAF%20inhibitor%20dabrafenib&journal=J%20Clin%20Pharmacol&doi=10.1002%2Fjcph.437&volume=55&pages=392-400&publication_year=2015&author=Suttle%2CAB&author=Grossmann%2CKF&author=Ouellet%2CD&author=Richards-Peterson%2CLE&author=Aktan%2CG&author=Gordon%2CMS is on a monthly basis
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Safety%2C%20tolerability%2C%20and%20pharmacokinetic%20profile%20of%20dabrafenib%20in%20Japanese%20patients%20with%20BRAF%20V600%20mutation-positive%20solid%20tumors%3A%20a%20phase%201%20study&journal=Investig%20New%20Drugs&doi=10.1007%2Fs10637-017-0502-8&volume=36&pages=259-268&publication_year=2018&author=Fujiwara%2CY&author=Yamazaki%2CN&author=Kiyohara%2CY&author=Yoshikawa%2CS&author=Yamamoto%2CN&author=Tsutsumida%2CA?
• Get to know https://doi.org/10.1002%2Fjcph.263's earnings
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24408395?
• How much does http://scholar.google.com/scholar_lookup?&title=Population%20pharmacokinetics%20of%20dabrafenib%2C%20a%20BRAF%20inhibitor%3A%20effect%20of%20dose%2C%20time%2C%20covariates%2C%20and%20relationship%20with%20its%20metabolites&journal=J%20Clin%20Pharmacol&doi=10.1002%2Fjcph.263&volume=54&pages=696-706&publication_year=2014&author=Ouellet%2CD&author=Gibiansky%2CE&author=Leonowens%2CC&author=O%E2%80%99Hagan%2CA&author=Haney%2CP&author=Switzky%2CJ gross monthly?
• How much revenue does https://doi.org/10.1124%2Fjpet.112.201475 generate?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23249624 earns monthly
• Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583506 earns monthly
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Mechanisms%20limiting%20distribution%20of%20the%20threonine-protein%20kinase%20B-RaF%28V600E%29%20inhibitor%20dabrafenib%20to%20the%20brain%3A%20implications%20for%20the%20treatment%20of%20melanoma%20brain%20metastases&journal=J%20Pharmacol%20Exp%20Ther&doi=10.1124%2Fjpet.112.201475&volume=344&pages=655-664&publication_year=2013&author=Mittapalli%2CRK&author=Vaidhyanathan%2CS&author=Dudek%2CAZ&author=Elmquist%2CWF generate?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25915534?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558166 gross monthly?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Trametinib%20modulates%20cancer%20multidrug%20resistance%20by%20targeting%20ABCB1%20transporter&journal=Oncotarget&volume=6&pages=15494-15509&publication_year=2015&author=Qiu%2CJ-G&author=Zhang%2CY-J&author=Li%2CY&author=Zhao%2CJ-M&author=Zhang%2CW-J&author=Jiang%2CQ-W
• Profit of https://doi.org/10.1124%2Fdmd.114.058339
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24875464 generate monthly?
• Learn how profitable http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109207 is on a monthly basis
• Get to know http://scholar.google.com/scholar_lookup?&title=Factors%20influencing%20the%20CNS%20distribution%20of%20a%20novel%20MEK-1%2F2%20inhibitor%3A%20implications%20for%20combination%20therapy%20for%20melanoma%20brain%20metastases&journal=Drug%20Metab%20Dispos&doi=10.1124%2Fdmd.114.058339&volume=42&pages=1292-1300&publication_year=2014&author=Vaidhyanathan%2CS&author=Mittapalli%2CRK&author=Sarkaria%2CJN&author=Elmquist%2CWF's earnings
• How much does https://doi.org/10.1200%2FJCO.2013.49.8691 pull in?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23918947
• How much profit does http://scholar.google.com/scholar_lookup?&title=Phase%20II%20trial%20%28BREAK-2%29%20of%20the%20BRAF%20inhibitor%20dabrafenib%20%28GSK2118436%29%20in%20patients%20with%20metastatic%20melanoma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2013.49.8691&volume=31&pages=3205-3211&publication_year=2013&author=Ascierto%2CPA&author=Minor%2CD&author=Ribas%2CA&author=Lebbe%2CC&author=O%E2%80%99Hagan%2CA&author=Arya%2CN generate?
• How much does https://doi.org/10.1016%2Fj.cca.2017.07.012 pull in monthly?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28709799 generate?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Trough%20dabrafenib%20plasma%20concentrations%20can%20predict%20occurrence%20of%20adverse%20events%20requiring%20dose%20reduction%20in%20metastatic%20melanoma&journal=Clin%20Chim%20Acta&doi=10.1016%2Fj.cca.2017.07.012&volume=472&pages=26-29&publication_year=2017&author=Rousset%2CM&author=Dutriaux%2CC&author=Bosco-L%C3%A9vy%2CP&author=Prey%2CS&author=Pham-Ledard%2CA&author=Dousset%2CL have monthly?
• https://doi.org/10.1111%2Fpcmr.12557's financial summary
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27863085 bring in each month?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Pharmacokinetics%20of%20dabrafenib%20in%20a%20patient%20with%20metastatic%20melanoma%20undergoing%20haemodialysis&journal=Pigment%20Cell%20Melanoma%20Res&doi=10.1111%2Fpcmr.12557&volume=30&pages=68-71&publication_year=2017&author=Park%2CJJ&author=Boddy%2CAV&author=Liu%2CX&author=Harris%2CD&author=Lee%2CV&author=Kefford%2CRF?
• How much profit does https://clinicaltrials.gov/ct2/show/NCT02873650 make?
• How much does https://doi.org/10.1124%2Fdmd.114.057778 rake in every month?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24748562?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=The%20metabolic%20drug%E2%80%93drug%20interaction%20profile%20of%20Dabrafenib%3A%20in%20vitro%20investigations%20and%20quantitative%20extrapolation%20of%20the%20P450-mediated%20DDI%20risk&journal=Drug%20Metab%20Dispos&doi=10.1124%2Fdmd.114.057778&volume=42&pages=1180-1190&publication_year=2014&author=Lawrence%2CSK&author=Nguyen%2CD&author=Bowen%2CC&author=Richards-Peterson%2CL&author=Skordos%2CKW?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=A%20study%20of%20the%20effects%20of%20inhibition%20of%20CYP3A4%20BY%20ketoconazole%20%28K%29%20and%20CYP2C8%20by%20gemfibrozil%20%28G%29%20on%20the%20pharmacokinetics%20dabrafenib%20%28D%29.%3A%20PII-085&journal=Clin%20Pharmacol%20Ther&volume=95&pages=S89-S90&publication_year=2014&author=Suttle%2CB&author=Grossmann%2CK&author=Richards-Peterson%2CL&author=Ouellet%2CD&author=Aktan%2CG&author=Gordon%2CM
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28101705
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488129?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Tyrosine%20kinase%20inhibitors%20and%20proton%20pump%20inhibitors%3A%20an%20evaluation%20of%20treatment%20options&journal=Clin%20Pharmacokinet&doi=10.1007%2Fs40262-016-0503-3&volume=56&pages=683-688&publication_year=2017&author=Leeuwen%2CRWF&author=Jansman%2CFGA&author=Hunfeld%2CNG&author=Peric%2CR&author=Reyners%2CAKL&author=Imholz%2CALT
• How much profit does https://doi.org/10.1097%2FCMR.0000000000000280 generate?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27399255?
• How much money does http://scholar.google.com/scholar_lookup?&title=Drug%20interaction%20between%20dabrafenib%20and%20immunosuppressive%20drugs%3A%20about%20one%20case&journal=Melanoma%20Res&doi=10.1097%2FCMR.0000000000000280&volume=26&pages=532-534&publication_year=2016&author=Levavasseur%2CM&author=Darras%2CS&author=Mortier%2CL&author=Goeminne%2CC&author=Auffret%2CM&author=Bertrand%2CM make?
• What are the earnings of https://doi.org/10.1016%2FS1470-2045%2816%2930578-2?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27864013's total income per month
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Factors%20predictive%20of%20response%2C%20disease%20progression%2C%20and%20overall%20survival%20after%20dabrafenib%20and%20trametinib%20combination%20treatment%3A%20a%20pooled%20analysis%20of%20individual%20patient%20data%20from%20randomised%20trials&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2816%2930578-2&volume=17&pages=1743-1754&publication_year=2016&author=Long%2CGV&author=Grob%2CJ-J&author=Nathan%2CP&author=Ribas%2CA&author=Robert%2CC&author=Schadendorf%2CD?
• How much does https://doi.org/10.1016%2Fj.ejca.2017.05.033 pull in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28648698 generate monthly?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Three-year%20pooled%20analysis%20of%20factors%20associated%20with%20clinical%20outcomes%20across%20dabrafenib%20and%20trametinib%20combination%20therapy%20phase%203%20randomised%20trials&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2017.05.033&volume=82&pages=45-55&publication_year=2017&author=Schadendorf%2CD&author=Long%2CGV&author=Stroiakovski%2CD&author=Karaszewska%2CB&author=Hauschild%2CA&author=Levchenko%2CE
• Check the income stats for https://doi.org/10.1093%2Fannonc%2Fmdu529
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25411413?
• How much does http://scholar.google.com/scholar_lookup?&title=Characteristics%20of%20pyrexia%20in%20BRAFV600E%2FK%20metastatic%20melanoma%20patients%20treated%20with%20combined%20dabrafenib%20and%20trametinib%20in%20a%20phase%20I%2FII%20clinical%20trial&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdu529&volume=26&pages=415-421&publication_year=2015&author=Menzies%2CAM&author=Ashworth%2CMT&author=Swann%2CS&author=Kefford%2CRF&author=Flaherty%2CK&author=Weber%2CJ earn?
• What's the income generated by https://doi.org/10.1038%2Fng.3060 each month?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25108385
• Profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999337
• How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20common%20missense%20variant%20in%20NUDT15%20confers%20susceptibility%20to%20thiopurine-induced%20leukopenia&journal=Nat%20Genet&doi=10.1038%2Fng.3060&volume=46&pages=1017-1020&publication_year=2014&author=Yang%2CS-K&author=Hong%2CM&author=Baek%2CJ&author=Choi%2CH&author=Zhao%2CW&author=Jung%2CY produce monthly?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24777842 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Genetics%20of%20immune-mediated%20adverse%20drug%20reactions%3A%20a%20comprehensive%20and%20clinical%20review&journal=Clin%20Rev%20Allergy%20Immunol&doi=10.1007%2Fs12016-014-8418-y&volume=48&pages=165-175&publication_year=2015&author=Yip%2CVLM&author=Alfirevic%2CA&author=Pirmohamed%2CM pull in monthly?
• What's the monthly income of https://doi.org/10.2217%2Fpgs.16.4?
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27023328 have?
• How much does http://scholar.google.com/scholar_lookup?&title=Pyrexia%20in%20dabrafenib-treated%20melanoma%20patients%20is%20not%20associated%20with%20common%20genetic%20variation%20or%20HLA%20polymorphisms&journal=Pharmacogenomics&doi=10.2217%2Fpgs.16.4&volume=17&pages=459-462&publication_year=2016&author=Kulkarni%2CD&author=Song%2CK&author=Briley%2CL&author=King%2CK&author=Dabrowski%2CC&author=Mookerjee%2CB pull in?
• https://doi.org/10.1111%2Fbcp.13488's financial summary
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29243287?
• How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867134 generate?
• http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20the%20effect%20of%20dabrafenib%20and%20metabolites%20on%20QTc%20interval%20in%20patients%20with%20BRAF%20V600-mutant%20tumours&journal=Br%20J%20Clin%20Pharmacol&doi=10.1111%2Fbcp.13488&volume=84&pages=764-775&publication_year=2018&author=Nebot%2CN&author=Arkenau%2CHTT&author=Infante%2CJR&author=Chandler%2CJC&author=Weickhardt%2CA&author=Lickliter%2CJD's total income per month
• How much income is https://doi.org/10.1002%2Fcpt.787 earning monthly?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28699160 make?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656880 make?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Practical%20recommendations%20for%20therapeutic%20drug%20monitoring%20of%20kinase%20inhibitors%20in%20oncology&journal=Clin%20Pharmacol%20Ther&doi=10.1002%2Fcpt.787&volume=102&pages=765-776&publication_year=2017&author=Verheijen%2CRB&author=Yu%2CH&author=Schellens%2CJHM&author=Beijnen%2CJH&author=Steeghs%2CN&author=Huitema%2CADR?
• Learn how profitable https://doi.org/10.1056%2FNEJMoa1412690 is on a monthly basis
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25399551 produce monthly?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Improved%20overall%20survival%20in%20melanoma%20with%20combined%20dabrafenib%20and%20trametinib&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1412690&volume=372&pages=30-39&publication_year=2015&author=Robert%2CC&author=Karaszewska%2CB&author=Schachter%2CJ&author=Rutkowski%2CP&author=Mackiewicz%2CA&author=Stroiakovski%2CD generate?
• How profitable is https://citation-needed.springer.com/v2/references/10.1007/s40262-018-0703-0?format=refman&flavour=references?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alicja%20Puszkiel rake in every month?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alicja%20Puszkiel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ga%C3%ABlle%20No%C3%A9?
• What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ga%C3%ABlle%20No%C3%A9%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Audrey%20Bellesoeur
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Audrey%20Bellesoeur%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nora%20Kramkimel
• What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nora%20Kramkimel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marie-No%C3%ABlle%20Paludetto's financial summary
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marie-No%C3%ABlle%20Paludetto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Audrey%20Thomas-Schoemann making per month?
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Audrey%20Thomas-Schoemann%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michel%20Vidal make?
• Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michel%20Vidal%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Fran%C3%A7ois%20Goldwasser
• How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Fran%C3%A7ois%20Goldwasser%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Etienne%20Chatelut?
• Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Etienne%20Chatelut%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Benoit%20Blanchet bring in?
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Benoit%20Blanchet%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• Income figures for https://s100.copyright.com/AppDispatchServlet?title=Clinical%20Pharmacokinetics%20and%20Pharmacodynamics%20of%20Dabrafenib&author=Alicja%20Puszkiel%20et%20al&contentID=10.1007%2Fs40262-018-0703-0©right=Springer%20Nature%20Switzerland%20AG&publication=0312-5963&publicationDate=2018-08-09&publisherName=SpringerNature&orderBeanReset=true
• Explore the financials of https://crossmark.crossref.org/dialog/?doi=10.1007/s40262-018-0703-0
• How much does https://citation-needed.springer.com/v2/references/10.1007/s40262-018-0703-0?format=refman&flavour=citation pull in?
• How much profit does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral make?
• Learn how profitable https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research is on a monthly basis
• How much cash flow does https://www.springernature.com/gp/products have monthly?
• How much profit is https://www.springernature.com/gp/librarians making per month?
• How much does https://www.springernature.com/gp/societies generate monthly?
• How profitable is https://www.springernature.com/gp/partners?
• What's the monthly money flow for https://www.springer.com/?
• What's the income generated by https://www.nature.com/ each month?
• What's the monthly money flow for https://www.biomedcentral.com/?
• How profitable is https://www.palgrave.com/?
• What are the total earnings of https://www.apress.com/?
• What's the revenue for https://www.springernature.com/gp/legal/ccpa?
• Monthly income for https://www.springernature.com/gp/info/accessibility
• How much does https://support.springernature.com/en/support/home rake in every month?
• Revenue of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
• How profitable is https://www.springernature.com/?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref